CNBC - Health
Eli Lilly to build $6 billion manufacturing plant in Alabama to help make obesity pill, other drugs
9 hours ago
A biotech stock for investors scared to invest in the risky industry10 hours ago
FDA approves Merck treatment for decimated U.S. cattle herds to stop screwworm13 hours ago
Pfizer adds to obesity bet with up to $2.1 billion deal with Chinese company13 hours ago
Bill Gates on why AI will become 'hyper competitive'16 hours ago
RFK Jr.'s vaccine panel weakens recommendation on hepatitis B shot for babies16 hours ago
RFK Jr.'s vaccine panel defers vote on hepatitis B shot for babies until Friday5 days ago
Jim Cramer has faith in Danaher's turnaround as life sciences comes back to life7 days ago
CEO using ChatGPT to talk to AI clones of business icons: 'Advice was so good'7 days ago
Eli Lilly slashes cash prices of Zepbound weight loss drug vials7 days ago
Abortion pill access steady under Trump as FDA review looms8 days ago
Republicans push Obamacare tax credit alternatives as enrollment deadline looms15 days ago
Novo Nordisk shares plunge after Alzheimer's drug trial fails to hit key target15 days ago
Eli Lilly hits $1 trillion market value as Novo Nordisk tumbles15 days ago
Why America's broken health system is an opportunity: Cityblock CEO Toyin Ajayi18 days ago
Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform21 days ago
Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month22 days ago
Congress hemp ban raises fears of mass layoffs and black market growth22 days ago
U.S. employer health plans tap prescriptions that feds say are illegal26 days ago
Healthy Returns: Novo Nordisk boosts the case for its obesity pill with new data26 days ago
Rocket Lab posts record third-quarter revenue, launch backlog28 days ago
Trump tells Republicans to send health insurance money 'directly to the people'28 days ago
Trump's deals with Eli Lilly, Novo Nordisk could broaden obesity drug access1 month ago
Startup Omada Health to start prescribing GLP-1s, other obesity medications1 month ago
Here's how much weight loss drugs could cost under Trump's deals with Lilly, Novo1 month ago
Trump announces deal with Eli Lilly, Novo Nordisk to cut weight loss drug prices1 month ago
Eli Lilly to start late-stage trials on amylin obesity drug after promising data1 month ago
Healthy Returns: Pfizer, Novo Nordisk escalate bidding war over Metsera1 month ago
Metsera says Novo Nordisk's new bid is 'superior' to revised Pfizer offer1 month ago
Pfizer tops estimates, raises profit guidance even as sales fall1 month ago
Pfizer files second lawsuit against Novo Nordisk, Metsera in obesity bidding war1 month ago
Where the blockbuster weight loss drug market stands today — and what's coming next1 month ago
'Trump effect' raises hopes for cannabis rally as investors bet on change1 month ago
Breast cancer drug stock Olema Pharmaceutical could more than double from here1 month ago
